For Ogweno Stephen, it’s personal, growing up in Kenya 🇰🇪, obesity was seen as prosperity, but it often meant health issues, stigma, and isolation. After #WorldObesityDay, the message is clear: LMICs can’t ignore adolescent obesity. 👉 medicinespatentpool.org/story-post/w...

For #WorldObesityDay, Nomathemba Chandiwana of the Desmond Tutu Health Foundation calls for action on barriers to care. #Obesity is rising worldwide 🌍, and the World Obesity Federation urges an end to stigma and equitable access to care ✨. 👉 medicinespatentpool.org/story-post/w...

Advances in cardiometabolic health bring hope for #obesity and type 2 diabetes, but access gaps remain 🌍 At MPP, we promote equitable #access through #voluntary #licensing. On #WorldObesityDay 🌱, we stand for healthier lives ❤️ 👉 www.worldobesityday.org #WOD2026 @worldobesity.bsky.social

Ahead of #WorldObesityDay 🌍, Ogweno Stephen 🇰🇪 highlights the rising childhood obesity crisis in LMICs. From facing obesity stigma in rural #Kenya, he now champions support for young people 🤝 and urges action on rising obesity, #diabetes, and #heart disease. @worldobesity.bsky.social

On #WorldObesityDay 🌏, Professor Francois Venter says obesity is a chronic disease shaped by systems and inequality. Medication and lifestyle support is essential. 8 billion reasons to act—fast, fair, coordinated. 👉 medicinespatentpool.org/story-post/w... #WOD2026 @worldobesity.bsky.social

Ahead of #WorldObesityDay, partners publish an open-access Comment in @thelancet.com Global Health on #GLP-1 #receptor agonists. Prevention and treatment are co-dependent, and stigma remains a major barrier to effective obesity care. 👉 doi.org/10.1016/S221... #WOD2026 #AccessToMedicines #NCDs

We’re delighted to welcome Christian Miculka to the @medicinespatentpool.org Governance Board! His expertise in human and animal health pharma will support MPP’s mission to expand access to #essential #medicines worldwide. 👉 medicinespatentpool.org/news-publica...

Meeting the UNAIDS 2030 targets could prevent 3.3 million new #HIV infections by 2030. 🌍 This depends on timely, affordable, and sustainable access across markets, and public health–oriented #voluntarylicensing is a proven way to help achieve it. 👉 https://medicinespatentpool.org/#HIV#voluntarylicensing#CROI2026

#RSV remains a major cause of infant illness and death worldwide 🌍, disproportionately affecting LMICs. Public health–oriented #voluntarylicensing, used in other disease areas, can help enable earlier access in these settings. 📩 [email protected]

Our MPP team is attending #CROI2026 in Denver, USA 🇺🇸 From February 22–25, join us at the Colorado Convention Center as we engage with partners and colleagues from around the world. Feel free to reach out to connect and explore new collaboration opportunities! 🌍 Unitaid

Excited to announce a SwiftPharma, Population Council, and MPP collaboration under Project ELYRA — advancing access to Griffithsin-based STI prevention.🤝 🔗 https://medicinespatentpool.org/partners/who-we-work-with#-Patent-Holders-Product-Developers-and-Resource-Programmes/

📍 Rome | 17–20 February 2026 We are pleased to join the #RSVVW26 Conference in Rome 🇮🇹, a global gathering dedicated to advancing novel preventative and therapeutic interventions against #RSV. If you’re attending the conference in Rome, let's connect! #ReSViNET #HealthConference #Globalhealth

#IDWGS2026 👩‍⚕️🧪“𝑨𝒔 𝒂 𝒅𝒐𝒄𝒕𝒐𝒓, 𝒚𝒐𝒖 𝒎𝒂𝒚 𝒔𝒂𝒗𝒆 𝒐𝒏𝒆 𝒑𝒆𝒓𝒔𝒐𝒏 𝒂𝒕 𝒂 𝒕𝒊𝒎𝒆. 𝑩𝒖𝒕 𝒘𝒉𝒆𝒏 𝒚𝒐𝒖 𝒄𝒓𝒆𝒂𝒕𝒆 𝒂 𝒗𝒂𝒄𝒄𝒊𝒏𝒆, 𝒚𝒐𝒖 𝒄𝒂𝒏 𝒔𝒂𝒗𝒆 𝒂𝒏 𝒆𝒏𝒕𝒊𝒓𝒆 𝒄𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚.” Huong Ngo Thu, 𝐏𝐨𝐥𝐲𝐯𝐚𝐜, 🇻🇳 www.youtube.com/watch?v=HVNK...

📍 158th @who.int Executive Board As discussions on health emergencies and #pandemicpreparedness continue, the @medicinespatentpool.org highlighted critical gaps in the production of essential #vaccines and health technologies. 👉 medicinespatentpool.org/news-publica...

#WorldCancerDay At MPP, we expand access to #cancer medicines via public health–oriented licences. In 2022, MPP signed the first-ever #voluntarylicence for a cancer medicine with @novartis.bsky.social, boosting access to nilotinib for CML with the @uiccofficial.bsky.social -led #ATOM consortium.

"We survived to be a voice for others.” - #WorldCancerDay A breast #cancer survivor, Gertrude Nakigudde now chairs the #UgandaWomen’sCancerSupportOrganization, amplifying patient voices in global efforts to expand access to cancer medicines. 👉 medicinespatentpool.org/story-post/w...

LAPaL provides long-acting medicinal product and drug delivery technology data Recently added: Risperidone LAI PGT-121 PGT-121.144.LS TLC ART combination therapy PGT-121.144.LS + VRC07-523LS Rifapentine Gemcitabine intravesical LAI system www.liverpool.ac.uk/celt-global-... @medicinespatentpool.org

🌍 We’re hiring! The Medicines Patent Pool (MPP) is looking for a Business Development In-Licensing Manager in Geneva! 👉 Learn more & apply by 20 Feb 2026: medicinespatentpool.org/call-for-app... #Hiring #BusinessDevelopment #Pharma #GlobalHealth

The Fifth Implementation Report of the #100DaysMission is a timely reminder that #pandemicpreparedness remains fragile, particularly when it comes to therapeutics and equitable access. 👉 lnkd.in/eR5UTgvD @ippsecretariat.org

🌍 MPP is hiring! In partnership with Ganci Partners, MPP is seeking an #ExecutiveDirector to lead our mission of delivering life-saving medicines to those who need them most. 📧 Apply by Feb 16, 2026 👉 lnkd.in/eyMVr_vj

Yesterday, the #AORTIC Medical Oncology Special Interest Group held a panel on Expanding #Immunotherapy #Access in Africa: Early Lessons and Cost Considerations 🌍 The discussion offered lessons for expanding equitable access to life-saving #treatments across the continent ✨

🎥 New MedsPaL Video Series! Continuing our mission to help users navigate the enhanced #MedsPaL platform! 🌍💊 🔍 You’ll learn how to explore #licence data efficiently and unlock valuable insights for your work! 🔗 Explore more at: www.medspal.org

⏰ Last days to submit your abstract to the #INTEREST2026 Conference! Provide a summary of your research for the chance to present at Africa’s premier conference dedicated to HIV/AIDS in May 2026. Abstract Submission Portal: virology.eventsair.com/Presentation... INTEREST: interestworkshop.org

🎙️ At #STEMSummit in New Delhi🇮🇳, MPP’s Andrew Spencer Goldman highlighted how licensing and tech transfer enable affordable access in LMICs—and why upstream agreements matter. Thanks to Pushpa Vijayaraghavan, MPP Board Member, for moderating! Learn more: bit.ly/49tNL7M

We’re hiring a Grants & Operations Officer to manage donor grants, reporting, and proposals. Be part of our mission to improve global access to medicines. Apply by 11 Jan 2026: medicinespatentpool.org/who-we-are/c...

🌍 On #UniversalHealthCoverageDay, Charles Gore reflects on a challenging yet rewarding 2025, a year marked by a changing landscape, strong collaboration with partners 🤝 and important milestones in expanding access to essential health products. 👉 medicinespatentpool.org/news-publica...

Behind every #licence that expands access to life-saving medicines are the people who make it possible. Our staff, from 🇨🇭 to 🇮🇳, stand together in this mission, because at MPP we know that when medicines are accessible, lives are saved. 👉 medicinespatentpool.org/licensingsav... #LicensingSavesLives

📍 MPP Booth #50 | ⏰ 12–1 PM Session: “The Last Mile: Innovation After Funding Cuts” with Michael Mhando & Victor Adula (@avac.org). Discussing access to medicines, health services for vulnerable populations & post-funding innovations. 👉 lnkd.in/e7DTMEYc @sebmoringva.bsky.social

📣 Discover today’s programme at #ICASA2025 — happening at Booth 50! We’re proud to highlight key moments of the day featuring the @medicinespatentpool.org team and partners. lnkd.in/e7DTMEYc #HIV #LongActing #GlobalHealth #AccessToMedicines #PublicHealth #EndingHIV #LeavingNoOneBehind

Yesterday, @who.int released its first-ever guideline on the use of GLP-1 therapies for adults living with obesity. This milestone follows the inclusion of GLP-1 medicines in the Essential Medicines List for managing type 2 diabetes in high-risk groups. 👉 www.who.int/news/item/01...

MPP and @unitaid.bsky.social are co-hosting “Breaking New Grounds: Long-Acting HIV Treatment for a New Generation”, at #ICASA2025. 📅 Wednesday 3 December 2025 | 11:45–12:30 GMT 📍 Room Prof. Souleymane Mboup & online Join us to discuss why long-acting HIV treatment matters. lnkd.in/e7DTMEYc

MPP joins @who.int @unaids.org @unitaid.bsky.social & partners to mark #WorldAIDSDay. Expanding access to dolutegravir-based regimens, paediatric formulations & long-acting therapeutics is vital for equity & choice. Through licensing, MPP helps make this possible. 🔗 shorturl.at/gEMKd

On #WorldAIDSDay, let's remember the role of #communities in driving the response, and how #access to optimal #HIV care - for everyone living with HIV - supports #solidarity and #dignity in the broader journey towards #progress 🤍

On #WorldAIDSDay, meet Dorothy from #Kenya 🇰🇪, a young mother who turned fear into hope through community support and access to paediatric #HIV treatment like #pALD. Her story shows that progress is more than medicine—it’s about solidarity and dignity. 🔗 shorturl.at/6S1Qv #BetterMeds4Kids

💊 Every pack of #HIV treatment delivered through MPP licences means a life transformed. Ahead of #WorldAIDSDay, meet Hue from #Vietnam, mother, advocate & fighter. W/ improved treatment & community support, she turned stigma into strength and now helps others do the same. 🔗 bit.ly/43Vpbe6

🌍 Around the world, millions of people cannot access the medicines they need — not because the treatments don’t exist, but because they remain out of reach. At MPP, we work to change that. ✨ Join us: lnkd.in/eDizXjQb Watch the video: www.youtube.com/watch?v=3kqd... #LicensingSavesLives

MPP’s work in #licensing, #techtransfer and capacity-building aligns with Article 12’s benefit-sharing goals. We’ve long partnered with @who.int and Member States to turn these principles into access. 🤝🌍 👉 medicinespatentpool.org/news-publica...

MPP provides sustainable solutions that save millions of lives in the short and long run. 🌍 MPP punches well above its weight. 💪 Would you like to explore ways in which we could collaborate? 🤝 Get in touch: medicinespatentpool.org/licensingsav... #Sustainability #FundingHealthEquity

One tablet could change everything. The UNIVERSAL 1 trial is confirming the right dose for a single, dispersible DTG/FTC/TAF pill for children with #HIV, a formulation prioritised by GAP-f. Watch for more #BetterMeds4Kids #WorldChildrensDay #PaediatricHIV #EDCTP

On #WorldChildrensDay, MPP proudly stands as a founding member of GAP-f, driving global collaboration to ensure children everywhere have access to lifesaving medicines. Learn more: www.who.int/initiatives/... @pablorojo.bsky.social @sebmoringva.bsky.social

🦠 #RSV kills 100,000+ young children yearly, 97% in LMICs. Prevention works, but access to life-saving monoclonal antibodies is limited. On #WorldChildrensDay, let’s push for affordable RSV prevention so every child gets a healthy start. Learn more: bit.ly/4o0XGqo

💊 Honored to welcome @medicinespatentpool.org to visit community-based organizations in Hanoi, with the connection from ViiV Healthcare. Together, we shared how community-led HIV prevention and care are helping expand access to essential medicines and health services for all.

Today is #WorldChildrensDay - It is a time to reflect and ask ourselves if we have continued to #prioritize #children this last year. While we never exclude children outright, we often forget to #adapt our #efforts to their #needs. Let's changed that & develop #BetterMeds4Kids! 🤍

Our MPP team will be attending ICASA 2025 in Accra, Ghana 🇬🇭, just two weeks to go! Feel free to reach out to connect and explore new collaboration opportunities. Together, we can advance global health.🌍 #ICASA2025 #PublicHealth @sebmoringva.bsky.social

This #FixedDoseCombination (combining 3 drugs in 1 tablet: #pALD) allows children to benefit from #innovation as adults have enjoyed for many years. This #equity supports #adherence and better #health outcomes for our loved young ones. 🤍 - #BetterMeds4Kids #WorldChildrensDay #ChildrenLivingWithHIV

As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶 Together, we continue to advance paediatric HIV care! 🤝

On #WorldDiabetesDay, we stand with @who.int’s call: #diabetes affects every life stage. Two inspiring women share their journeys through #pregnancy with #Type1diabetes— highlighting urgent needs for affordable #insulin, tech access, and #education. No one should be left behind. 🔗 bit.ly/3WYVNzB

We're thrilled to welcome Mathieu Saint-Arnaud, Managing Director at Deutsche Bank, to the MPP's Governance Board! Mathieu’s expertise and global outlook will be invaluable as we advance MPP’s mission to improve access to #essential #medicines worldwide. 👉 medicinespatentpool.org/news-publica...

On #WorldPneumoniaDay, we spotlight #RSV — the leading cause of severe #pneumonia in infants. 100,000 child deaths yearly, 97% in LMICs. Prevention is critical, and access must improve. Read how MPP is driving change: medicinespatentpool.org/story-post/p... #BetterMeds4Kids

#RSV causes 100,000 child deaths yearly — almost entirely in LMICs. On #WPD, MPP calls for urgent action to make prevention tools like #nirsevimab and #clesrovimab widely accessible, esp. in LMICs. Voluntary licensing can help close the gap. Learn more: medicinespatentpool.org/story-post/p...